Accelerate access. Extend adherence. Deliver value.
Sciensus is a leading European hub of integrated services with 30 years’ experience in navigating the complex European healthcare ecosystem to maximise patient access to medicines, product launches and full commercialisation.
Discover our services
We support trial continuity and patient logistics across Europe – with proven delivery models in complex markets requiring precision, multilingual engagement and regulatory fluency.
Clinical trials
We support trial continuity and patient logistics across Europe – with proven delivery models in complex markets requiring precision, multilingual engagement and regulatory fluency.
Early access programmes and market access
We enable safe, compliant access to therapies across Europe – from unlicensed medicine delivery to early access programmes with multilingual support.
Aseptic compounding
We prepare and deliver complex, high-value therapies with hospital-grade precision – including oncology and specialty medicines administered at home, supported by regulatory-compliant workflows.
Supply chain and logistics
We streamline the referral-to-care process – combining trusted clinician relationships, multilingual support, and industry-leading dispense and delivery to ensure patients start treatment safely and quickly.
Treatment delivery and ongoing engagement
We deliver therapy safely through clinician-led medication, track adherence in real time, and keep patients engaged through digital tools, multilingual clinical teams, and cross-border logistics.
Evidence generation
We capture real-world data, patient-reported outcomes, and adherence trends – generating evidence that meets both global standards and local regulatory expectations across Europe. We also provide comprehensive pharmacovigilance solutions at a country-by-country level.
Global expertise, local execution
Sciensus offers a single partner to manage the complexity of commercialising a drug across Europe – with a faster route to reaching and supporting patients and gathering insights to maximise your European launch.
Expertise across therapeutic areas
Through more than 30 years of in-market expertise, evidence and insights, we’re unlocking the complex European market. We’ll help you accelerate your development journey and bring products directly to patients with expert patient care and digitally enhanced tools.
Cancer services
We’re the leading provider of at-home cancer care. With expert clinical teams and proven expertise in technology, logistics and patient support, we help patients start treatments sooner and engage them holistically with their care.
Rare & speciality
We provide end-to-end rare and speciality disease expertise, offering bespoke solutions that navigate complexity and accelerate access – ensuring treatments reach the patients who need them most across Europe.
Chronic conditions
We support 300,000 patients annually across 70 therapy areas with in-person care and innovative digital tools. Our Intouch app improves adherence and delivers real-world insights to enhance healthcare decisions.
Our impact
With 30+ years of in-market expertise, Sciensus has superior access to patients – our distribution and clinical care infrastructure enables us to help you get the right drug to the right patients faster and then we can provide the personalised support to drive adherence, reduce drop-off and collect real world data.
0
patient interactions
0
patients treated annually
0 +
regimens supported across 125 different medicines
0
relationships with hospitals, clinics and pharmacies in Europe
Scalability
Expertise
Bespoke solutions
As a strategic partner, they have exceeded our expectations by finding global patients, who need our drugs, and enabling them to receive their life-extending medications.
Chief Commercial Officer at leading US Biotech company
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.
News and insights
Blogs
How can we support patients to personalise their cancer treatment?
For many people, having cancer is a disempowering experience that they feel they have little control over. Chemotherapy remains a…
Thought Leadership
Expand into Europe: unlocking the orphan drug market
Blogs
An introduction to PASS studies
PASS studies: optimising and simplifying observational safety and efficacy studies If you’re looking to launch a new orphan drug in…